Journal Articles
Extended-Release Formulation and Medication Adherence
October 28, 2019
Featured Experts: John Romley, PhD, Dana Goldman, PhD
Research
All Research Featured Research
Evidence Base
Are We Ready to Treat Alzheimer’s?
October 25, 2019
Featured Experts: Jakub Hlávka, PhD
Perspective
It’s Hard to Lower Drug Prices, If You Don’t Know What They Are
October 21, 2019
Featured Experts: Neeraj Sood, PhD
Journal Articles
Prescription Opioid Use in General and Pediatric Emergency Departments
October 16, 2019
Featured Experts: Michael Menchine, MD, MPH, Sanjay Arora, MD
News
Young People Treated in Pediatric Emergency Departments Less Likely to Receive Opioids Compared to Similar Patients Treated in General EDs
October 16, 2019
Featured Experts: Michael Menchine, MD, MPH
Perspective
CBO Estimate on Pelosi Drug Bill Misses its Long-Term Impact on Health
October 16, 2019
Featured Experts: Dana Goldman, PhD
Data Visualization
Future Health Dividends for California: Valuing Medical Innovations
October 15, 2019
Featured Experts: Bryan Tysinger, PhD, Karen Mulligan, PhD, Dana Goldman, PhD
Evidence Base
A Value-Based System Where Healthcare Providers are Accountable for Outcomes Will Benefit Patients
October 14, 2019
Perspective
Accounting for Hope: Using ‘Mean Survival Gain’ to Price New Cancer Drugs
October 14, 2019
Featured Experts: Alice Chen, PhD, Dana Goldman, PhD
Evidence Base
Innovations in Probability-Based Internet Panel Data: Exploring the Understanding America Study
October 8, 2019
News
Newly Approved Cancer Drugs Are Pricey, But Also Show Improved Longer-Term Survival Gains
October 7, 2019
Featured Experts: Alice Chen, PhD, Dana Goldman, PhD
Journal Articles
Expanding the Role of the Patient-Centered Outcomes Research Institute: Reauthorization and Facilitating Value Assessments
October 5, 2019
Featured Experts: William Padula, PhD
Journal Articles
Trends in the Use of Skilled Nursing Facility and Home Health Care Under the Hospital Readmissions Reduction Program: An Interrupted Time-series Analysis
October 1, 2019
Featured Experts: Neeraj Sood, PhD
Evidence Base
Who Would Have Believed it? Markets Can Reduce the ‘True’ Price of Cancer Drugs
September 28, 2019
Featured Experts: Dana Goldman, PhD
Perspective
California Saw Reduction in Out-of-Network Care from Affected Specialties after 2017 Surprise Billing Law
September 26, 2019
Featured Experts: Erin L. Duffy, PhD, MPH, Bich Ly, Erin Trish, PhD
Journal Articles
Analysis of State-Level Drug Pricing Transparency Laws in the United States
September 25, 2019
Featured Experts: Neeraj Sood, PhD
News
Most State Laws Aimed at Improving Drug Pricing Transparency Won’t Help, According to New Study
September 25, 2019
Featured Experts: Neeraj Sood, PhD